Alexion Pharmaceuticals to Present Data on Soliris(R) (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting

CHESHIRE, Conn., Nov. 9 Alexion Pharmaceuticals,Inc. (Nasdaq: ALXN) today announced that data relating to paroxysmal nocturnalhemoglobinuria (PNH), as well as to Soliris(R) (eculizumab) as a treatment forpatients with PNH, have been published by the American Society of Hematology(ASH). Abstracts will be presented at the 2007 ASH annual meeting that isbeing held December 8 to 11, 2007 at the Georgia World Congress Center inAtlanta.

The following abstracts will be presented in a poster session on red cellregulation and disorders of production on Monday, December 10, 2007. Theabstracts and presentation information can be accessed at the links providedbelow.

The following abstract will be presented in an oral session on red cellregulation and disorders of production on Tuesday, December 11, 2007. Theabstract and presentation information can be accessed at the link providedbelow.-- "High Incidence of Progression to Chronic Renal Insufficiency in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)" Dr. Peter Hillmen et al. http://www.abstracts2view.com/hem07/view.php?nu=HEM07L1_5416 -- "Sustained Improvements in Transfusion Requirements, Fatigue and Thrombosis with Eculizumab Treatment in Paroxysmal Nocturnal Hemoglobinuria" Dr. Gerard Socie et al. http://www.abstracts2view.com/hem07/view.php?nu=HEM07L1_5204 -- "Disease.Related Symptoms Reported across a Broad Population of Patients with Paroxysmal Nocturnal Hemoglobinuria" Dr. Gabrielle Meyers et al. http://www.abstracts2view.com/hem07/view.php?nu=HEM07L1_5438.

SOURCE Alexion Pharmaceuticals, Inc.

Latest Press Release on General News

Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis

The Danaher Beacon for Brain Injury Diagnostics seeks to identify mild Traumatic Brain Injury (TBI) earlier and more precisely. Scientists will evaluate new blood-based biomarkers usi...

Philips Shareholders Approve all Proposals at the AGM 2024

May 7, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shar...

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterin...

Nicklaus Children's Health System, Philips to Provide Innovative Patient and Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic c...

Cinesteam® Is a Deodorizing Support Tool for Palliative Care

Palliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings. FOR...